<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Amrute JM</submitter><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pubmed_abstract>Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction. However, the molecular mechanisms driving immune-fibroblast crosstalk in human cardiac disease remains unexplored and there are currently no therapeutics to target fibrosis. Here, we performed multi-omic single-cell gene expression, epitope mapping, and chromatin accessibility profiling in 38 donors, acutely infarcted, and chronically failing human hearts. We identified a disease-associated fibroblast trajectory marked by cell surface expression of fibroblast activator protein (FAP), which diverged into distinct myofibroblasts and pro-fibrotic fibroblast populations, the latter resembling matrifibrocytes. Pro-fibrotic fibroblasts were transcriptionally similar to cancer associated fibroblasts and expres</pubmed_abstract><journal>Research square</journal><pagination>rs.3.rs-2402606</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9900986</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis.</pubmed_title><pmcid>PMC9900986</pmcid><funding_grant_id>P30 CA091842</funding_grant_id><funding_grant_id>P30 AR073752</funding_grant_id><funding_grant_id>R01 HL138466</funding_grant_id><funding_grant_id>R35 HL161185</funding_grant_id><funding_grant_id>R01 HL151078</funding_grant_id><funding_grant_id>R01 HL139714</funding_grant_id><pubmed_authors>Ma P</pubmed_authors><pubmed_authors>Lee P</pubmed_authors><pubmed_authors>Heo GS</pubmed_authors><pubmed_authors>Kuppe C</pubmed_authors><pubmed_authors>Lavine KJ</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Bredemeyer A</pubmed_authors><pubmed_authors>Koenig AL</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li CM</pubmed_authors><pubmed_authors>Kadyrov F</pubmed_authors><pubmed_authors>Furtado M</pubmed_authors><pubmed_authors>Kramann R</pubmed_authors><pubmed_authors>Amrute JM</pubmed_authors><pubmed_authors>Ason B</pubmed_authors><pubmed_authors>Kreisel D</pubmed_authors><pubmed_authors>Penna V</pubmed_authors><pubmed_authors>Terada Y</pubmed_authors><pubmed_authors>Fu A</pubmed_authors><pubmed_authors>Stitziel NO</pubmed_authors><pubmed_authors>Yamawaki T</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Hayat S</pubmed_authors><pubmed_authors>Yang S</pubmed_authors><pubmed_authors>Kopecky B</pubmed_authors><pubmed_authors>Shi SY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis.</name><description>Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction. However, the molecular mechanisms driving immune-fibroblast crosstalk in human cardiac disease remains unexplored and there are currently no therapeutics to target fibrosis. Here, we performed multi-omic single-cell gene expression, epitope mapping, and chromatin accessibility profiling in 38 donors, acutely infarcted, and chronically failing human hearts. We identified a disease-associated fibroblast trajectory marked by cell surface expression of fibroblast activator protein (FAP), which diverged into distinct myofibroblasts and pro-fibrotic fibroblast populations, the latter resembling matrifibrocytes. Pro-fibrotic fibroblasts were transcriptionally similar to cancer associated fibroblasts and expres</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-06-25T03:13:55.865Z</modification><creation>2026-06-25T03:07:51.782Z</creation></dates><accession>S-EPMC9900986</accession><cross_references><pubmed>36747878</pubmed><doi>10.21203/rs.3.rs-2402606/v1</doi></cross_references></HashMap>